Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Vaccine Product Services In Europe
4 services found
Manufactured by:Nuvonis based inVienna, AUSTRIA
The generation of high titer vaccines with acceptable purity is a challenging task, both regarding upstream and downstream steps. Upstream development uses well established technologies such as bioreactors (e.g., single use) or high-cell density systems based on microcarrier technology. An integral part of process development is the fine funing between cell substrate, virus ...
Manufactured by:Sartorius AG based inGoettingen, GERMANY
Following a streamlined workflow, we combine powerful spent media analysis with intelligent DoE and process simulations in order to reach your objectives in the most efficient way. Cell lines for development include e.g. CHO, HEK, Hybridoma and BHK while targets comprise protein production, transfection, vaccine, production and AAV / lentivirus ...
Manufactured by:CycloLab Cyclodextrin Research and Development Laboratory Ltd. based inBudapest, HUNGARY
Cyclodextrins have been used in food products and nutraceutics for decades as stabilizers for flavors and colorants, solubilizers of vitamins and lipophilic components, taste and odor maskers or to improve hygroscopicity, powder properties, even as dietary fibers. Alpha-, beta- and gamma cyclodextrins are on the GRAS list. ...
Manufactured by:ProBioGen AG based inBerlin, GERMANY
You want to overcome the historic way to manufacture viral vaccines on embryonated chicken eggs or on finite cultures of primary avian and mammalian origin. You want to avoid challenges in supply and scalability, variable performance, and increasing costs for source material and extensive safety testing. You are looking for a modern serum-free process avoiding traditional, ...